Immunome, Inc. (NASDAQ:IMNM – Get Rating) was the target of a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 162,700 shares, a growth of 25.6% from the March 15th total of 129,500 shares. Based on an average daily trading volume, of 50,600 shares, the […]